
Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.
Combined male-/female-factor infertility in couples results in the highest costs for treatment compared to male-factor or female-factor infertility only.
San Francisco-Combined male-/female-factor infertility in couples results in the highest costs for treatment compared to male-factor or female-factor infertility only, report researchers from the University of California, San Francisco.
Infertile couples should be given a realistic estimate of longer-term costs associated with fertility treatment to help them with the decision-making process, recommended first author James F. Smith, MD, assistant professor of urology at UCSF.






